Thousand Oaks-based Amgen Inc. and Allergan plc, headquartered in Dublin, Ireland, on Friday announced two biosimilar drugs for cancer treatment which the companies co-developed are now for sale in the United States....

Subscribe to get the full story.


Are you a subscriber? Sign In